General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Primary Care

The Established Medicines franchise comprises of over 200 products in many areas of medicine that are commercialized all over the world.

Established Medicines products include:

  • Clozaril/Leponex (clozapine)
  • Coartem/Riamet (artemether and lumefantrine)
  • Famvir (famciclovir)
  • Focalin & Focalin XR (dexmethylphenidate HCl & dexmethylphenidate modified release)
  • Foradil (formoterol)
  • Lamisil (terbinafine)
  • Lescol/Lescol XL (fluvastatin sodium)
  • Lotensin/Cibacen (benazepril hydrochloride)
  • Lotensin HCT/Cibadrex (benazepril hydrochloride and hydrochlorothiazide)
  • Miacalcin/Miacalcic (salmon calcitonin)
  • Reclast/Aclasta (zoledronic acid/zoledronic acid 5 mg)
  • Ritalin & Ritalin LA (methylphenidate HCl & methylphenidate HCl modified release)
  • Tegretol (carbamazepine)
  • Trileptal (oxcarbazepine)
  • Vivelle Dot/Estradot (estradiol hemihydrate)
  • Voltaren/Cataflam (diclofenac sodium/potassium)